Adipose-derived stem cell exosomes: from functional mechanisms to clinical translation in diabetic foot ulcer management
-
By
-
Xintong Zhong
-
Guohui Wu
-
May 29, 2026
-
Clinical Scorecard: Exosomes from Adipose-Derived Stem Cells: Exploring Mechanisms and Clinical Applications for Managing Diabetic Foot Ulcers
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | ADSC-Exos alleviate oxidative stress, modulate inflammation, promote angiogenesis, stimulate cell proliferation and migration, and suppress excessive fibrosis, leading to improved healing outcomes. |
| Target Population | |
| Care Setting | |
Key Highlights
- ADSC-Exos represent a promising cell-free therapy for DFUs.
- Current treatment strategies yield suboptimal outcomes, necessitating novel approaches.
- ADSC-Exos facilitate healing through multiple biological mechanisms.
- Challenges include variability in exosome cargo and a lack of robust human clinical trials, which must be addressed.
- Innovative delivery strategies may enhance clinical translation.
Guideline-Based Recommendations
Diagnosis
Management
- Current standards include surgical debridement, specialized dressings, and pressure off-loading.
- Consider integrating ADSC-Exos into treatment plans for DFUs.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Diabetic patients with a high risk of developing DFUs.
ADSC-Exos may provide a novel therapeutic option, addressing limitations of traditional therapies.
Clinical Best Practices
- Consider integrating ADSC-Exos into treatment plans for DFUs.
- Utilize advanced delivery methods to enhance the efficacy of ADSC-Exos.
- Monitor patient outcomes closely using specific metrics to assess the effectiveness of new therapies.
Related Resources & Content
